Substance Use Disorder Didactic Presentations
- 6/4/20: Managing Pain in Patients with Substance Use Disorder
- Additional Resources:
- 5/21/20: Novel/Designer Benzodiazepines
- Additional Resources:
- 5/7/20: SUD Peers in COVID-19
- Additional Resources:
- 3/18/20: COVID-19
- 3/5/20: Micro-Induction of Buprenorphrine
- 2/20/20: Introduction to Harm Reduction
- 2/6/20: Trauma and Addiction
- 1/16/20: Medications for OUD: who should get what when
- 12/19/19: Maternal substance use disorders and infant withdrawal syndromes in hospital deliveries among American Indians/Alaska Natives in Washington
- 12/5/19: Micro-induction of buprenorphine/naloxone
- 11/21/19: Introduction to PrEP
- 11/7/19: Complex Persistent Dependence, Withdrawal, and Opioid Use Disorder
- 10/17/19: Integrating SUD Data at your I/T/U clinic
- 10/3/19: Creating Affirming Clinic Environments for Two Spirit and LGBTQ Patients
- 9/19/19: How to Start a Naloxone Program – A Brief Didactic for Tribes
- 9/5/19: Methamphetamine Use Disorder
- 8/15/19: Case Presentations and Treatment Recommendations
- 8/1/19: Introduction to Methadone
- 7/18/19: Case Presentations and Treatment Recommendations
- 6/20/19: Trauma Informed Care
- 6/6/19: Choosing to Start a MAT Program at Siletz Tribal Health
- 5/16/19: Treating Pain in the setting of Prescription OUD
- 5/2/19: Culture-based Strategies for SUD: Decolonizing Addiction
- 4/18/19: The Role of Behavioral Interventions in Substance Use Disorder Treatment
- 4/4/19: Alcohol Use Disorder – Treatment and Clinical Recommendations
- 3/21/19: Introduction to Peer Recovery Mentors
- 3/7/19: Language of Addiction Memo – Changing Federal Terminology Regrading Substance Use and Substance Use Disorders
- 2/21/19: Opioid Treatment Failure
- 2/7/19: Medications for OUD: Who should get what when?
- 1/17/19: Neurobiology and Diagnosis of Substance Use Disorders
To access any of the above presentations, please contact echo@npaihb.org